Atlas Trials

A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Clinical trial NCT01363713 · COMPLETED

Trial details

NCT number
NCT01363713
Sponsor
Santen Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Primary completion
2012-09-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.